BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Sunesis Pharmaceuticals, Inc. 

395 Oyster Point Boulevard
Suite 400
South San Francisco  California  94080  U.S.A.
Phone: 650-266-3500 Fax: 650-266-3501


SEARCH JOBS


Industry
Pharmaceutical

Segment
Biotechnology

Collaborations

Merck & Co., Inc.  Alzheimer's disease, Antivirals

Biogen Idec, Inc. (California)  Cancer Therapeutics

Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)  Inflammatory and Autoimmune Diseases





 Company News
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS 4/8/2014 7:37:18 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) Announces MD Anderson Cancer Center Sponsored Trial Of Vosaroxin In AML And High-Risk MDS Poster To Be Presented At American Association for Cancer Research 2014 4/2/2014 8:53:57 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Fourth Quarter And Full-Year 2013 Financial Results And Recent Highlights 3/6/2014 9:18:36 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At Upcoming Investor Conferences 2/28/2014 9:58:06 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On March 6th To Discuss Fourth Quarter And Full-Year 2013 Financial Results And Recent Highlights 2/28/2014 9:26:47 AM    More...
Bay Area's Sunesis Pharmaceuticals, Inc. (SNSS) Prices $43 Million Common Stock And Warrants 2/27/2014 7:31:38 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) Appoints Joseph I. Depinto As Chief Commercial Officer, Updates VALOR Timeline To Unblinding Of Data 2/10/2014 9:10:24 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At Upcoming Investor Conferences 2/6/2014 9:09:12 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) Expands Hematology Franchise With Global Licenses To Two Kinase Inhibitor Programs 1/9/2014 9:57:39 AM    More...
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Initiation Of An Investigator-Sponsored Trial Evaluating Vosaroxin In Combination With Azacitidine In MDS 12/10/2013 9:21:11 AM    More...
12345678910...

//-->